SCHEMBL23946339

SCHEMBL23946339

Cc1nc(-c2ccccc2)c2cc(-c3ccc4ccccc4c3)cc(-c3ccccc3)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.41
ADORA1 P30542 3/20 0.41
CYP17A1 P05093 1/20 0.38
CYP19A1 P11511 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
AKT1 P31749 1/20 0.38
CSNK1D P48730 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
HSD17B1 P14061 2/20 0.37
HSD17B2 P37059 2/20 0.37
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23946303 0.90 KDM4E (0.38) ADORA2ASMN1; SMN2KDM4EALDH1A1HSD17B10
SCHEMBL23946321 0.89 L3MBTL1 (0.39) SMN1; SMN2KDM4EALDH1A1CYP1A2HSD17B10
SCHEMBL23946301 0.87 CRHR1 (0.36) ADORA1HSD17B1HSD17B2SMN1; SMN2KDM4E
SCHEMBL23946338 0.84 CRHR1 (0.38) CSNK1DMAPK11MAPK14SMN1; SMN2KDM4E
SCHEMBL23946255 0.82 CRHR1 (0.36) SMN1; SMN2KDM4EALDH1A1CYP1A2HSD17B10
SCHEMBL23946336 0.81 PIK3CD (0.48) ADORA2AADORA1CYP17A1CYP19A1CYP11B1
SCHEMBL16436544 0.81 ADORA2A (0.44) ADORA2AADORA1CYP17A1CYP19A1CYP11B1
SCHEMBL16436546 0.78 CYP1A1 (0.46) ADORA2AADORA1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL16436540 0.78 CYP1A1 (0.46) ADORA2AADORA1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL16436832 0.78 CYP1A1 (0.46) ADORA2AADORA1CYP1A1CYP1B1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210328153-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES Beijing Summer Sprout Technology Co., Ltd. (CN) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210328153-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES IDO1, IDO2, AZI2 ADORA2A 333/4885ADORA1 1072/4885CYP17A1 3852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.